Dbv technologies to participate in upcoming investor conference

Montrouge, france, september 5, 2023 d bv technologies to participate in upcoming investor conference dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced the company will participate in the h.c. wainwright annual global investment conference taking place on september 11th −13th in new york, ny.
DBVT Ratings Summary
DBVT Quant Ranking